ESMO 2025: J&J eyes Rybrevant indication expansion to HNSCC on Phase II victory
The bispecific’s efficacy and safety will now be explored through a Phase III trial in first-line HNSCC.
Lundbeck and Contera partner for oligonucleotide-based medicines
ESMO 2025: Eli Lilly’s Verzenio extends survival in high-risk early breast cancer
Infertility treatment amongst first drugs included on FDA’s new priority voucher scheme
Market dynamics for generics must change amid ANDA pilot debut
ESMO 2025: Novartis’s Pluvicto delays progression to end-stage for mHSPC
Analysis
View More
Themes
View MoreHuawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
During HUAWEI CONNECT 2025, Leo Chen, Senior Vice President, President of Enterprise Sales, Huawei, emphasised the focus is on how to harness AI’s full potential.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?
Trump blames Covid-19 drugmakers for fuelling CDC turmoil
Oxford University and Ellison Institute link for AI vaccine research